Literature DB >> 8754856

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase.

P M Vertino1, R W Yen, J Gao, S B Baylin.   

Abstract

Recent studies showing a correlation between the levels of DNA (cytosine-5-)-methyltransferase (DNA MTase) enzyme activity and tumorigenicity have implicated this enzyme in the carcinogenic process. Moreover, hypermethylation of CpG island-containing promoters is associated with the inactivation of genes important to tumor initiation and progression. One proposed role for DNA MTase in tumorigenesis is therefore a direct role in the de novo methylation of these otherwise unmethylated CpG islands. In this study, we sought to determine whether increased levels of DNA MTase could directly affect CpG island methylation. A full-length cDNA for human DNA MTase driven by the cytomegalovirus promoter was constitutively expressed in human fibroblasts. Individual clones derived from cells transfected with DNA MTase (HMT) expressed 1- to 50-fold the level of DNA MTase protein and enzyme activity of the parental cell line or clones transfected with the control vector alone (Neo). To determine the effects of DNA MTase overexpression on CpG island methylation, we examined 12 endogenous CpG island loci in the HMT clones. HMT clones expressing > or = 9-fold the parental levels of DNA MTase activity were significantly hypermethylated relative to at least 11 Neo clones at five CpG island loci. In the HMT clones, methylation reached nearly 100% at susceptible CpG island loci with time in culture. In contrast, there was little change in the methylation status in the Neo clones over the same time frame. Taken together, the data indicate that overexpression of DNA MTase can drive the de novo methylation of susceptible CpG island loci, thus providing support for the idea that DNA MTase can contribute to tumor progression through CpG island methylation-mediated gene inactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754856      PMCID: PMC231454          DOI: 10.1128/MCB.16.8.4555

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  X-chromosome inactivation and cell memory.

Authors:  A D Riggs; G P Pfeifer
Journal:  Trends Genet       Date:  1992-05       Impact factor: 11.639

Review 2.  CpG islands and genes.

Authors:  S H Cross; A P Bird
Journal:  Curr Opin Genet Dev       Date:  1995-06       Impact factor: 5.578

3.  Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts.

Authors:  P M Vertino; J P Issa; O M Pereira-Smith; S B Baylin
Journal:  Cell Growth Differ       Date:  1994-12

4.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Authors:  J G Herman; A Merlo; L Mao; R G Lapidus; J P Issa; N E Davidson; D Sidransky; S B Baylin
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

5.  5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

Authors:  A Merlo; J G Herman; L Mao; D J Lee; E Gabrielson; P C Burger; S B Baylin; D Sidransky
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

6.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

7.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

Authors:  J R Graff; J G Herman; R G Lapidus; H Chopra; R Xu; D F Jarrard; W B Isaacs; P M Pitha; N E Davidson; S B Baylin
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

8.  Suppression of intestinal neoplasia by DNA hypomethylation.

Authors:  P W Laird; L Jackson-Grusby; A Fazeli; S L Dickinson; W E Jung; E Li; R A Weinberg; R Jaenisch
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

9.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.

Authors:  J P Issa; Y L Ottaviano; P Celano; S R Hamilton; N E Davidson; S B Baylin
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

10.  Mammalian DNA (cytosine-5-)-methyltransferase expressed in Escherichia coli, purified and characterized.

Authors:  T O Tollefsbol; C A Hutchison
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

View more
  74 in total

1.  In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b.

Authors:  C L Hsieh
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription.

Authors:  F Fuks; W A Burgers; N Godin; M Kasai; T Kouzarides
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 4.  The marks, mechanisms and memory of epigenetic states in mammals.

Authors:  V K Rakyan; J Preis; H D Morgan; E Whitelaw
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

5.  DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation.

Authors:  Matthew C Lorincz; Dirk Schübeler; Shauna R Hutchinson; David R Dickerson; Mark Groudine
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  Dnmt3L is a transcriptional repressor that recruits histone deacetylase.

Authors:  Rachel Deplus; Carmen Brenner; Wendy A Burgers; Pascale Putmans; Tony Kouzarides; Yvan de Launoit; François Fuks
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

Review 7.  Aberrant DNA methylation in human cancers.

Authors:  Wen Li; Bi-Feng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

8.  Predicting aberrant CpG island methylation.

Authors:  F A Feltus; E K Lee; J F Costello; C Plass; P M Vertino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

9.  Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.

Authors:  J A Mikovits; H A Young; P Vertino; J P Issa; P M Pitha; S Turcoski-Corrales; D D Taub; C L Petrow; S B Baylin; F W Ruscetti
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Suppressing effects of down-regulating DNMT1 and DNMT3b expression on the growth of human cholangiocarcinoma cell line.

Authors:  Shi Zuo; Jian Luo; Minfeng Liu; Lining Xu; Jingqing Dong; Wei Guo; Shengquan Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.